peer review


It is the responsibility of the drug company seeking to market a drug must have it tested and submit evidence that it’s safe and effective. A team of CDER physicians, statisticians, chemist, pharmacologist, and other scientists reviews the sponsor’s NDA containing the data and the proposed labeling.Which the labeling should contain any possible side effects, how the medicine should be taken and inform the patient of the dangers of this medicine becoming addictive and the misuses of this medicine could be deadly.

How does the reaction of law enforcement to this crisis differ from their response to the crack epidemic of 1980? The 1980s drug crisis was the “Crack Epidemic ” stereotypically portrayed as a phenomenon of ” the violent black inner city”, focusing on the criminally dangerous drug addict. The harm caused by the epidemic was not as severe as the media sensationalized.However, the resulting punitive approaches of the “War on Drugs ” with harsh sentencing and mandatory minimums disproportionately affected communities of color with devastating effects.

Today we’re shown a different face in the opioid crisis —a white one.Since 2001 the opioid overdose death rate amongst non-Hispanics whites have been higher than non-Hispanic blacks and have sharply increased in recent years. With this new face comes a new response: rather than demonizing substance use as criminal behavior, our nation emphasizes treatment and public health intervention.

The solutions :

1.we need to employ a health equity approach by promoting policies that will equally benefit diverse populations: communities of color and white communities, rural and urban, young and old, wealthy and disadvantaged.

2. We need to use a strategy that says, “We don’t have to wait until a problem has a white face to answer with humanity.” This means calling out specific injustices when we encounter them, including Attorney General Jeff Sessions’ return to punitive policies for drug crimes. It also means building diverse coalitions to promote our policy issues.

I truly believe everyone plays a part in the drug crisis,It doesn’t matter what color you are. The person who makes the drugs and knows they are dangerous and addictive, to the ones who take the drugs and gets hooked on them.We know there’s a problem that has gotten worse and has been around for decades. Programs to help people get off the drugs and educating them to stay they drugs and making stronger laws and guidelines for the drug companies who make them.This is certainly a problem that is not going to be easy to fix but they have to try, people are dying because of this epidemic.

Resources from:

Health Policy Hub · Orla Kennedy


Hi Class,

I think 50 percent of the responsibility fall on the drug companies for distributing highly addictive drugs. I say 50 percent because the drug companies are making and selling to the Dr. Offices and hospitals. These companies are not selling or giving directly to the population. Now should they try and invest in finding drugs that give the same result but less addicting or even not addicting at all, yes but that wouldn’t be beneficial to them because their profits would drop. This is the concept I’m sure of making a drug that the population will continually purchase, which in turn make them richer. However these companies don’t oversee who gets the drugs once they are sold. That responsibility then lye on the organizations or doctors who buy them for their patients. I feel the responsibility then lye on the doctors because if they didn’t prescribe the drugs the public wouldn’t have easy access to the drugs. The reaction to law enforcement to this crisis verses the crack epidemic in 1980 seems to be more relaxed. I think law enforcement isn’t doing enough to stop what is happening. I do see the law suit to be a start of trying to get some sort of reform going and in place but I don’t think that it is enough. In my opinion I feel two solutions would be for the monitoring of who the drugs are being prescribed to. For example is the drugs being prescribed to patients for long term pain relief or patients who has short term medical necessity? Secondly, I think a cut off period needs to be in place according to medical opinion of how long these type of drugs can be prescribed for a certain type of illness. I’m sure this wouldn’t cut down on the overuse but it would make these type of drugs harder to abuse or get.